Compumedics Ltd (ASX:CMP) chief executive officer David Burton shares key reasons why investors should look at the stock during Proactive's Lifesciences Webinar on Tuesday, August 10.
Established in 1987, the global technology leader has so far focused on the fast-growing, high value sleep medicine market.
It is now also focusing on the associated fields of neuro-diagnostics and brain research.